Price Alert

AxoGen Inc. (AXGN)

NASDAQ: AXGN · Real-Time Price · USD

14.89

0.13 (0.88%)

At close: Aug 14, 2025, 3:59 PM

14.90

0.07%

Pre-market: Aug 15, 2025, 08:45 AM EDT

0.88% (1D)

Bid	14.5
Market Cap	685.13M
Revenue (ttm)	203.27M
Net Income (ttm)	-4.66M
EPS (ttm)	-0.1
PE Ratio (ttm)	-148.9
Forward PE	28.96
Analyst	Buy

Ask	15.5
Volume	1,160,103
Avg. Volume (20D)	1,101,383
Open	14.53
Previous Close	14.76
Day's Range	14.10 - 14.94
52-Week Range	9.22 - 21.00
Beta	0.99

About AXGN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AXGN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AXGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

AxoGen has released their quartely earnings on Aug 5, 2025:

Revenue of $56.66M exceeds estimates by $3.94M, with 18.26% YoY growth.

EPS of 0.12 exceeds estimates by 0.10, with 140.00% YoY growth.

Next Earnings Release

AxoGen Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+9.32%

Axogen shares are trading higher after the company... Unlock content with Pro Subscription

3 months ago

-23.18%

Axxogen shares are trading lower after the company reported a Q1 adjusted EPS miss.

News

2 days ago · zacks.com

Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 76.4% in AxoGen (AXGN). While the effectiveness of this highly sought-after metric is questionable, the positiv...

2 days ago · seekingalpha.com

Axogen: Broad Range Of Outcomes Still Present, Opting To Remain Sidelined

Axogen is compounding business capital at increasing returns which was reflected in Q2 earnings. The stock remains in a down-trend with investors compressing multiples paid on capital invested into th...

1 week ago · fool.com

Axogen (AXGN) Q2 Revenue Jumps 18%

1 week ago · seekingalpha.com

Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript

Axogen, Inc. (NASDAQ:AXGN ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Jens Schroeder Kemp - Chief Marketing Officer Lindsey Hartley - Chief Financial Officer Mich...

1 week ago · zacks.com

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.

2 weeks ago · zacks.com

AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · zacks.com

AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for AxoGen (AXGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in ...